shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of Clinical Sites for the Undiagnosed Diseases Network (U01 - Clinical Trial Not Al

    NOT-NS-23-008

    Argenia Doss, Ph.D.

    Opening date 22 Jul 2022, 12:00AM

    Closing date N/A

    Funding Opportunity Number: NOT-NS-23-008

    Opportunity Category: Discretionary

    Expected Number of Awards: 11

    CFDA Number(s): 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders

    Cost Sharing or Matching Requirement: No

    Posted Date: Jul 22, 2022 12:00:00 AM EDT

    Closing Date: N/A

    Estimated Total Program Funding: 6500000

    Award Ceiling: $400000

    Eligible Applicants:

    Description: This Notice informs the research community that the participating NIH Institutes and Centers intend to publish a Funding Opportunity Announcement (FOA) limited to those institutions and Program Directors/Principal Investigators (PD/PI) of Undiagnosed Diseases Network (UDN) Clinical Sites who received an NIH award under the NIH Common Fund UDN program through RFA-RM-17-019. The purpose of this Limited Competition FOA is to allow these UDN Clinical Sites an opportunity to compete for one additional year of NIH funding to: continue their participation in the UDN; establish collaborations and efficient processes with the next phase Data Management and Coordinating Center (DMCC; see: RFA-NS-22-051); enroll and evaluate new participants; and further develop their sustainability plans as the network transitions to a sustainable national resource. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.  The FOA is expected to be published in August, 2022 with an expected application due date in September, 2022. This FOA will utilize the U01 activity code. Only Renewal applications will be allowed.

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept